Analysis reveals distinct immune profiles in GVHD and infection-related diarrhea post-allo-HSCT, suggesting a predictive model may enhance clinical decisions.
Key Points
Diarrhea differentiation relies on immune profiling, enhancing clinical diagnosis and treatment strategies.
Higher cytokine levels characterize GVHD-associated diarrhea, aiding in early diagnosis.
Endoscopic evaluation with histopathology assists in confirming the diagnosis of diarrhea causes post-transplant.
The predictive model enables improved decision-making for treatment of diarrhea post-allo-HSCT.